These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 10975769

  • 1. Efficacy of pantoprazole in the prevention of peptic ulcers, induced by non-steroidal anti-inflammatory drugs: a prospective, placebo-controlled, double-blind, parallel-group study.
    Bianchi Porro G, Lazzaroni M, Imbesi V, Montrone F, Santagada T.
    Dig Liver Dis; 2000 Apr; 32(3):201-8. PubMed ID: 10975769
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and tolerability of pantoprazole compared with misoprostol for the prevention of NSAID-related gastrointestinal lesions and symptoms in rheumatic patients.
    Stupnicki T, Dietrich K, González-Carro P, Straszak A, Terjung A, Thomas KB, Lühmann R, Fischer R.
    Digestion; 2003 Apr; 68(4):198-208. PubMed ID: 14707396
    [Abstract] [Full Text] [Related]

  • 3. Prevention of NSAID-associated gastrointestinal lesions: a comparison study pantoprazole versus omeprazole.
    Regula J, Butruk E, Dekkers CP, de Boer SY, Raps D, Simon L, Terjung A, Thomas KB, Lühmann R, Fischer R.
    Am J Gastroenterol; 2006 Aug; 101(8):1747-55. PubMed ID: 16817839
    [Abstract] [Full Text] [Related]

  • 4. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs.
    Taha AS, Hudson N, Hawkey CJ, Swannell AJ, Trye PN, Cottrell J, Mann SG, Simon TJ, Sturrock RD, Russell RI.
    N Engl J Med; 1996 May 30; 334(22):1435-9. PubMed ID: 8618582
    [Abstract] [Full Text] [Related]

  • 5. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL, Huang B, Amer F, Christopoulos NG.
    Clin Ther; 2004 Oct 30; 26(10):1637-43. PubMed ID: 15598480
    [Abstract] [Full Text] [Related]

  • 6. Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine.
    Ehsanullah RS, Page MC, Tildesley G, Wood JR.
    BMJ; 1988 Oct 22; 297(6655):1017-21. PubMed ID: 3142593
    [Abstract] [Full Text] [Related]

  • 7. Misoprostol for small bowel ulcers in patients with obscure bleeding taking aspirin and non-steroidal anti-inflammatory drugs (MASTERS): a randomised, double-blind, placebo-controlled, phase 3 trial.
    Taha AS, McCloskey C, McSkimming P, McConnachie A.
    Lancet Gastroenterol Hepatol; 2018 Jul 22; 3(7):469-476. PubMed ID: 29754836
    [Abstract] [Full Text] [Related]

  • 8. [Superiority of pantoprazole over ranitidine in the treatment of duodenal ulcer. Mexican clinical experience. Mexican Study Group of Pantoprazole++ in Duodenal Ulcer].
    Dibildox M, Rose K, Tomás-Pons J, Fischer R, Gallo S.
    Rev Gastroenterol Mex; 1996 Jul 22; 61(3):193-8. PubMed ID: 9102740
    [Abstract] [Full Text] [Related]

  • 9. Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term non-steroidal anti-inflammatory drug (NSAID) therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial.
    Sugano K, Kontani T, Katsuo S, Takei Y, Sakaki N, Ashida K, Mizokami Y, Asaka M, Matsui S, Kanto T, Soen S, Takeuchi T, Hiraishi H, Hiramatsu N.
    J Gastroenterol; 2012 May 22; 47(5):540-52. PubMed ID: 22388884
    [Abstract] [Full Text] [Related]

  • 10. Sulglycotide in the prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal mucosal injury. A controlled double-blind, double-dummy, randomized endoscopic study versus placebo in rheumatic patients.
    Bianchi Porro G, Montrone F, Petrillo M, Caruso I, Ardizzone S.
    Scand J Gastroenterol; 1993 Oct 22; 28(10):875-8. PubMed ID: 8266016
    [Abstract] [Full Text] [Related]

  • 11. Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole.
    Graham DY, Agrawal NM, Campbell DR, Haber MM, Collis C, Lukasik NL, Huang B, NSAID-Associated Gastric Ulcer Prevention Study Group.
    Arch Intern Med; 2002 Jan 28; 162(2):169-75. PubMed ID: 11802750
    [Abstract] [Full Text] [Related]

  • 12. Double-blind comparison of pantoprazole and omeprazole for the treatment of acute duodenal ulcer.
    Beker JA, Bianchi Porro G, Bigard MA, Delle Fave G, Devis G, Gouerou H, Maier C.
    Eur J Gastroenterol Hepatol; 1995 May 28; 7(5):407-10. PubMed ID: 7614102
    [Abstract] [Full Text] [Related]

  • 13. [Clinical superiority of pantoprazole over ranitidine in the treatment of reflux esophagitis grade II and III. A prospective, double-blind, double-placebo study. Mexican clinical experience. Mexican Pantoprazole Study Group].
    Gallo S, Dibildox M, Moguel A, Di Silvio M, Rodríguez F, Almaguer I, García C.
    Rev Gastroenterol Mex; 1998 May 28; 63(1):11-6. PubMed ID: 10068743
    [Abstract] [Full Text] [Related]

  • 14. A double-blind study of pantoprazole and ranitidine in treatment of acute duodenal ulcer. A multicenter trial. European Pantoprazole Study Group.
    Cremer M, Lambert R, Lamers CB, Delle Fave G, Maier C.
    Dig Dis Sci; 1995 Jun 28; 40(6):1360-4. PubMed ID: 7781461
    [Abstract] [Full Text] [Related]

  • 15. Pantoprazole infusion as adjuvant therapy to endoscopic treatment in patients with peptic ulcer bleeding: prospective randomized controlled trial.
    Zargar SA, Javid G, Khan BA, Yattoo GN, Shah AH, Gulzar GM, Sodhi JS, Mujeeb SA, Khan MA, Shah NA, Shafi HM.
    J Gastroenterol Hepatol; 2006 Apr 28; 21(4):716-21. PubMed ID: 16677158
    [Abstract] [Full Text] [Related]

  • 16. Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders.
    Fitton A, Wiseman L.
    Drugs; 1996 Mar 28; 51(3):460-82. PubMed ID: 8882382
    [Abstract] [Full Text] [Related]

  • 17. A review of treatment of duodenal and gastric ulcers--pantoprazole vs. omeprazole.
    Schepp W, Rehner M, Witzel L.
    Aliment Pharmacol Ther; 1994 Mar 28; 8 Suppl 1():53-7. PubMed ID: 8180295
    [Abstract] [Full Text] [Related]

  • 18. Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors.
    Scheiman JM, Yeomans ND, Talley NJ, Vakil N, Chan FK, Tulassay Z, Rainoldi JL, Szczepanski L, Ung KA, Kleczkowski D, Ahlbom H, Naesdal J, Hawkey C.
    Am J Gastroenterol; 2006 Apr 28; 101(4):701-10. PubMed ID: 16494585
    [Abstract] [Full Text] [Related]

  • 19. Continuous infusion of pantoprazole versus ranitidine for prevention of ulcer rebleeding: a U.S. multicenter randomized, double-blind study.
    Jensen DM, Pace SC, Soffer E, Comer GM, 315 Study Group.
    Am J Gastroenterol; 2006 Sep 28; 101(9):1991-9; quiz 2170. PubMed ID: 16968504
    [Abstract] [Full Text] [Related]

  • 20. Pantoprazole versus omeprazole in the treatment of acute gastric ulcers.
    Witzel L, Gütz H, Hüttemann W, Schepp W.
    Aliment Pharmacol Ther; 1995 Feb 28; 9(1):19-24. PubMed ID: 7766739
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.